Literature DB >> 21492351

Serial measurements of exercise performance in pediatric heart transplant patients using stress echocardiography.

Joanne P Yeung1, Derek G Human, George G S Sandor, Astrid M De Souza, James E Potts.   

Abstract

Heart transplantation is an increasingly acceptable therapeutic option for children with end-stage and complex congenital heart disease. With advances in surgery, immunosuppression, and follow-up care, functional outcomes need to be evaluated. We report the results of serial exercise testing performed using stress echocardiography in a cohort of pediatric HTP. HTP (n = 7) exercised on a semi-recumbent ergometer to volitional fatigue. Echocardiography-Doppler measurements, HR, and blood pressure were taken at rest and during staged exercise. Results were compared with healthy CON (n = 12). HTP did significantly less work during exercise (940 vs. 1218 J/kg, p < 0.03). Their SVI (33 vs. 49 mL/m(2), p < 0.003), CI (5.16 vs. 9.25 L/min/m(2), p < 0.0005), and HR (162 vs. 185 bpm, p < 0.02) were lower at peak exercise. HTP had a lower SF at peak exercise (48% vs. 52%, p < 0.03) and an abnormal relationship between the MVCFc and σPS. During follow-up, hemodynamics and left ventricular function remained relatively constant in HTP. HTP are able to exercise safely; however, their exercise tolerance is reduced, and hemodynamics and contractility are diminished. Over time, their hemodynamics and left ventricular function have remained relatively constant.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492351     DOI: 10.1111/j.1399-3046.2010.01467.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

1.  Supine cycling in pediatric exercise testing: disparity in performance measures.

Authors:  Lindsay J May; Rajesh Punn; Inger Olson; Jeffrey A Kazmucha; Michael Y Liu; Clifford Chin
Journal:  Pediatr Cardiol       Date:  2013-11-20       Impact factor: 1.655

2.  Semi-supine exercise stress echocardiography in children and adolescents: feasibility and safety.

Authors:  P Ciliberti; I McLeod; F Cairello; J P Kaski; M Fenton; A Giardini; J Marek
Journal:  Pediatr Cardiol       Date:  2014-11-20       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.